# Endocrine Cell Metadata Analysis Session Log - Updated

**Date**: 2025-09-08  
**Session Type**: Re-analysis with deduplicated metadata and dataset organization  
**Location**: /scratch/rli/project/agent/metadata/  
**Previous Session**: 2025-09-01 (64 datasets, potentially duplicated)

## Overview
Re-analyzed endocrine cell datasets using deduplicated metadata from `/scratch/rli/project/agent/data_integration/unique_datasets_metadata_final.csv`. Now working with 55 unique datasets containing 92,510 endocrine cells across 14.5 million total cells. Created organized tables with tissue mapping and filtered datasets for high endocrine enrichment (>1%).

## Session Timeline

### Phase 1: Data Source Update
**Time**: Start of session  
**Action**: Switched from original metadata to deduplicated version
- **Original**: 64 datasets, 100,628 endocrine cells, 16.3M total cells
- **Updated**: 55 unique datasets, 92,510 endocrine cells, 14.5M total cells
- **Source**: `/scratch/rli/project/agent/data_integration/unique_datasets_metadata_final.csv`

### Phase 2: Re-run All Analysis Scripts
**Scripts executed**:
1. `analyze_endocrine_metadata.py`
2. `visualize_endocrine_relationships.py`
3. `create_cooccurrence_heatmaps.py`
4. `analyze_endocrine_metadata_mapped.py`
5. `create_cooccurrence_heatmaps_mapped.py`

**Updated Key Findings**:
- Total endocrine cells: 92,510 (reduced from 100,628)
- Total cells analyzed: 14.5 million (reduced from 16.3 million)
- Average endocrine percentage: 2.04% (increased from 1.97%)
- 17 unique endocrine cell types (same as before)
- 73 unique tissues documented (same)
- 26 disease states studied (25 excluding normal)

**Updated Top Cell Types**:
1. Enteroendocrine cells (21 datasets, down from 24)
2. Neuroendocrine cells (12 datasets, down from 17)
3. Lung neuroendocrine cells (10 datasets, down from 11)

**Updated Top Tissues**:
1. Ileum (17 datasets, down from 19)
2. Lung (16 datasets, down from 19)
3. Duodenum (12 datasets, down from 14)
4. Colon (10 datasets, down from 11)

### Phase 3: Dataset Organization Tables
**Time**: Mid-session  
**New Scripts Created**:
- `create_organized_table.py`
- `create_filtered_table.py`

**Table Features Added**:
1. **Dataset ID as first column** for easy reference
2. **Tissue mapping** to 13 categories:
   - Large Intestine (30.3% of occurrences)
   - Small Intestine (25.0%)
   - Lung/Respiratory (15.9%)
   - Stomach (7.7%)
   - Pancreas (2.9%)
   - Others (Reproductive, Esophagus, Liver/Biliary, etc.)
3. **In vitro/In vivo classification**:
   - 12 in vitro samples
   - 43 in vivo samples
4. **Author/Collection extraction** from metadata
5. **Disease and technology information**

### Phase 4: Filtered Dataset Creation (>1% Endocrine)
**Rationale**: Focus on datasets with meaningful endocrine enrichment

**Filtering Results**:
- **Datasets retained**: 17 of 55 (30.9%)
- **Endocrine cells retained**: 73,274 of 92,510 (79.2%)
- **Average enrichment in filtered**: 5.93% (vs 2.04% overall)
- **Cells in filtered datasets**: 2.45 million

**Top Enriched Datasets**:
1. Pancreatic islets: 42.49% endocrine (1,081/2,544 cells)
2. Lung organoid: 19.56% endocrine (13,792/70,495 cells)
3. Columnar cells (GI): 6.76% endocrine (5,378/79,522 cells)
4. Lung organoid atlas: 6.57% endocrine (14,548/221,425 cells)
5. NSCLC epithelial: 3.36% endocrine (329/9,778 cells)

### Phase 5: Updated Documentation
**Files Updated**:
- `ENDOCRINE_METADATA_INSIGHTS.md` - Updated with new statistics
- All visualization files regenerated with new data

**New Files Created**:
- `endocrine_datasets_organized_table.csv` - Full dataset table with mapping
- `endocrine_datasets_organized_table.md` - Markdown version
- `endocrine_datasets_filtered_table.csv` - Filtered (>1% endocrine)
- `endocrine_datasets_filtered_table.md` - Markdown version

## Key Insights from Updated Analysis

### 1. Data Quality Improvements
- Removed 9 duplicate datasets
- Cleaner statistics with unique datasets only
- Higher average endocrine percentage (2.04% vs 1.97%)

### 2. Tissue Distribution Patterns (Mapped)
**GI System Dominance Confirmed**:
- Large Intestine: 63 occurrences (30.3%)
- Small Intestine: 52 occurrences (25.0%)
- Combined GI: 55.3% of all tissue occurrences

**Respiratory System Secondary**:
- Lung/Respiratory: 33 occurrences (15.9%)

**GI vs Respiratory Ratio**: 4.88x (slightly lower than previous 5.0x)

### 3. Disease Association Updates
**Updated Co-occurrence Statistics**:
- 144 tissue-disease pairs (down from 175)
- 47 cell type-disease pairs (down from 59)
- 43 tissues with disease associations (same)
- 14 endocrine cell types linked to diseases (same)

**Disease Categories (Updated)**:
- Cancer: 16 occurrences (26%, down from 28%)
- Inflammatory: 7 occurrences (11%, down from 12%)
- Metaplasia: 4 occurrences (7%, down from 9%)
- Infectious: 4 occurrences (7%, up from 6%)

### 4. Technology Distribution
**10x Genomics Dominance**:
- 10x 3' v2: 31 datasets
- 10x 3' v3: 27 datasets
- Combined 10x: 58 of 87 technology mentions

### 5. Enrichment Strategy Insights
**High-value datasets (>1% endocrine)**:
- Only 30.9% of datasets
- Contain 79.2% of all endocrine cells
- Average 5.93% enrichment
- More efficient for endocrine cell studies

**Tissue preferences in enriched datasets**:
- Small Intestine: 10 datasets
- Large Intestine: 9 datasets
- Lung/Respiratory: 4 datasets
- Pancreas: 2 datasets (highest enrichment)

## Clinical and Research Implications

### 1. Sampling Strategy
- Focus on the 17 high-enrichment datasets for efficient endocrine cell capture
- Pancreatic islets remain gold standard (42.49%)
- Organoid systems show promise (often >5% enrichment)

### 2. Disease Research Priorities
- GI diseases well-represented (Crohn's, IBD, gastritis)
- Cancer studies prominent but slightly reduced
- COVID-19 emerging as important context

### 3. Technical Considerations
- 10x platforms adequate for most studies
- Smart-seq2 for deep profiling of enriched samples
- Consider enrichment strategies for <1% populations

## Comparison Summary

| Metric | Original (2025-09-01) | Updated (2025-09-08) | Change |
|--------|----------------------|---------------------|---------|
| Total Datasets | 64 | 55 | -14.1% |
| Total Endocrine Cells | 100,628 | 92,510 | -8.0% |
| Total Cells | 16.3M | 14.5M | -11.0% |
| Avg Endocrine % | 1.97% | 2.04% | +3.6% |
| Tissue-Disease Pairs | 175 | 144 | -17.7% |
| Cell Type-Disease Pairs | 59 | 47 | -20.3% |

## Files in Metadata Directory

**Analysis Scripts** (5):
- `analyze_endocrine_metadata.py`
- `analyze_endocrine_metadata_mapped.py`
- `visualize_endocrine_relationships.py`
- `create_cooccurrence_heatmaps.py`
- `create_cooccurrence_heatmaps_mapped.py`
- `create_organized_table.py` (NEW)
- `create_filtered_table.py` (NEW)

**Documentation** (2+2 NEW):
- `ENDOCRINE_METADATA_INSIGHTS.md` (updated)
- `README.md`
- `endocrine_datasets_organized_table.md` (NEW)
- `endocrine_datasets_filtered_table.md` (NEW)

**Data Files** (2 NEW):
- `endocrine_datasets_organized_table.csv` (NEW)
- `endocrine_datasets_filtered_table.csv` (NEW)

**Visualizations** (12 files - 6 PDFs, 6 PNGs):
- All regenerated with updated data

## Key Takeaways

1. **Data deduplication improved quality**: Removed redundancy, cleaner statistics
2. **GI dominance confirmed**: 55.3% of tissue occurrences
3. **Enrichment strategy validated**: 17 datasets with >1% contain 79% of endocrine cells
4. **Pancreatic islets remain gold standard**: 42.49% enrichment
5. **Organoids show promise**: Often higher enrichment than primary tissue
6. **Disease associations slightly reduced**: But patterns remain consistent

## Next Steps Recommendations

1. **Focus on 17 high-enrichment datasets** for detailed analysis
2. **Prioritize pancreatic and lung organoid datasets** for method development
3. **Investigate tissue-specific enrichment strategies**
4. **Consider spatial transcriptomics** for in situ validation
5. **Develop computational enrichment methods** for low-percentage datasets

---
**Session Duration**: ~30 minutes  
**Files Created/Updated**: 13 files (7 scripts, 4 documentation, 2 data tables)  
**Key Finding**: 17 datasets with >1% endocrine enrichment contain 79.2% of all endocrine cells  
**Status**: ✅ Complete with improved data quality